Action CS Diagnostics (PK) - CSDX

CS Diagnostics Corporation (PK) (CSDX) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

0,033

( - )

Prix Achat

0,033

Prix Vente

0,039

Volume échangé

11 850

0,033 Fourchette du Jour 0,039

0,033 Plage de 52 semaines 0,40

Cap du marché

8,25M

Clôture Veille

0,033

Ouverture

0,039

Dernière Transaction

10500

0.033

Dernière heure de transaction

Volume financier

US$ 395

VWAP

0,033362

Volume moyen (3 m)

US$ 137 096

Actions en circulation

249 992 200

Rendement du Dividende (LTM)

Ratio Cours sur Bénéfices

116,2

Bénéfice par action (BPA)

Chiffre d'affairess (LTM)

204k

Bénéfice net (LTM)

71,22k

CS Diagnostics Corp. engages in designing, manufacturing, and selling of wellness and medical products in Germany and internationally. The company offers MEDUSA, proprietary surface disinfectant protection product; and CS-Protect Hydrogel, a proprietary oncology medical device used in radiation ther... CS Diagnostics Corp. engages in designing, manufacturing, and selling of wellness and medical products in Germany and internationally. The company offers MEDUSA, proprietary surface disinfectant protection product; and CS-Protect Hydrogel, a proprietary oncology medical device used in radiation therapy. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The company was incorporated in 1996 and is based in Cheyenne, Wyoming. Show more

Secteur

Healthcare

Industrie

Medical Equipment & Supplies

Site Web

csdcorp.us

Siège social

Cheyenne, United States

Fondé

1996

CS Diagnostics Corporation (PK) est coté dans le secteur Healthcare de la OTC Markets avec le ticker CSDX. Le dernier cours de clôture d'CS Diagnostics (PK) était de US$0,03. Au cours de la dernière année, les actions de CS Diagnostics (PK) ont été négociées dans une fourchette de prix de US$ 0,033 à US$ 0,40.

CS Diagnostics (PK) compte actuellement 249 992 200 actions en circulation. La capitalisation boursière d'CS Diagnostics (PK) est de US$8,25 million. CS Diagnostics (PK) a un ratio cours/bénéfice (ratio PE) de 116.20.

Form 8-K - Current report

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend]

CS Group (OTCQB: CSDX) Appoints Shah Teelani & Associates, a Dubai-Based PCAOB Auditor, to Consolidate All 2025 Financial Statements for CSDX, CS Interpharm GT LLC and CS Diagnostics Pharma GmbH

CHEYENNE, Wyo., Feb. 11, 2026 (GLOBE NEWSWIRE) -- CS Diagnostics Corp. (OTCQB: CSDX) (“CS Group” or the...

Form 3 - Initial statement of beneficial ownership of securities

CS Group (OTCQB: CSDX) Secures Strategic Manufacturing Partnerships, Accelerating Global Commercial Launch of MEDUSA SDP Hygiene Products

CHEYENNE, Wyo., Jan. 29, 2026 (GLOBE NEWSWIRE) -- CS Diagnostics Corp. (OTCQB: CSDX), a medical technology...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-0.0027	-7.56302521008	0.0357	0.039	0.033	4775	0.03311308	CS
4	-0.02476	-42.8670360111	0.05776	0.0679	0.033	171451	0.03812307	CS
12	-0.1133	-77.4436090226	0.1463	0.177	0.033	139338	0.07357295	CS
26	-0.255	-88.5416666667	0.288	0.398	0.033	94768	0.11088215	CS
52	-0.065	-66.3265306122	0.098	0.4	0.033	61402	0.11633195	CS
156	-0.743344	-95.7493070082	0.776344	3.5	0.033	60650	0.13758577	CS
260	-0.743344	-95.7493070082	0.776344	3.5	0.033	60650	0.13758577	CS

CSDX - Frequently Asked Questions (FAQ)

What is the current CS Diagnostics Corporation (PK) share price?

The current share price of CS Diagnostics Corporation (PK) is US$ 0,033

How many CS Diagnostics Corporation (PK) shares are in issue?

CS Diagnostics Corporation (PK) has 249 992 200 shares in issue

What is the market cap of CS Diagnostics Corporation (PK)?

The market capitalisation of CS Diagnostics Corporation (PK) is USD 8,25M

What is the 1 year trading range for CS Diagnostics Corporation (PK) share price?

CS Diagnostics Corporation (PK) has traded in the range of US$ 0,033 to US$ 0,40 during the past year

What is the PE ratio of CS Diagnostics Corporation (PK)?

The price to earnings ratio of CS Diagnostics Corporation (PK) is 116,2

What is the cash to sales ratio of CS Diagnostics Corporation (PK)?

The cash to sales ratio of CS Diagnostics Corporation (PK) is 40,44

What is the registered address of CS Diagnostics Corporation (PK)?

The registered address for CS Diagnostics Corporation (PK) is 1603 Capitol Avenue, Cheyenne, Wyoming, 82001

What is the CS Diagnostics Corporation (PK) website address?

The website address for CS Diagnostics Corporation (PK) is csdcorp.us/

Which industry sector does CS Diagnostics Corporation (PK) operate in?

CS Diagnostics Corporation (PK) operates in the Medical Equipment & Supplies sector

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

CS Diagnostics Corporation (PK) (CSDX)

CS Diagnostics Corporation (PK) (CSDX) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de CS Diagnostics Corporation (PK)

CSDX Dernières nouvelles

Form 8-K - Current report

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend]

CS Group (OTCQB: CSDX) Appoints Shah Teelani & Associates, a Dubai-Based PCAOB Auditor, to Consolidate All 2025 Financial Statements for CSDX, CS Interpharm GT LLC and CS Diagnostics Pharma GmbH

Form 3 - Initial statement of beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

CS Group (OTCQB: CSDX) Secures Strategic Manufacturing Partnerships, Accelerating Global Commercial Launch of MEDUSA SDP Hygiene Products

Form 8-K - Current report

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend]

CS Group (OTCQB: CSDX) Appoints Shah Teelani & Associates, a Dubai-Based PCAOB Auditor, to Consolidate All 2025 Financial Statements for CSDX, CS Interpharm GT LLC and CS Diagnostics Pharma GmbH

Form 3 - Initial statement of beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

CSDX - Frequently Asked Questions (FAQ)

CSDX Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Sign up for FREE and get:

Supprimer les publicités